Impax to Acquire Tower Holdings, Inc. and Lineage Therapeutics Inc.


McDermott served as legal counsel to Impax Laboratories, a technology based specialty pharmaceutical company, in its $700 million acquisition of two privately held companies that focus on the development, manufacture and commercialization of complex generic and branded pharmaceutical products. Read the full article